Advertisement

Spinal Tech

Stryker beat industry analysts and reported $1.39 earnings per share in the third quarter, a 11.2 percent year-over-year improvement , but what's next for the orthopedic device maker?

Advertisement

Cambridge, Mass.-based InVivo Therapeutics enrolled a new patient in its INSPIRE Study, testing the Neuro-Spinal Scaffold's efficacy and safety for complete thoracic AIS A spinal cord injury.

Advertisement